Supriya Peshin, Internal Medicine Resident Physician at Ballad Health, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Publication Alert.
Gastroenteropancreatic neuroendocrine tumors are heterogeneous malignancies with limited curative options despite advances in targeted therapy, radionuclide therapy, and chemotherapy. The modest efficacy of current treatments underscores the urgent need for novel strategies.
This review highlights ongoing phase II–III clinical trials exploring innovative agents and combinations that may reshape the therapeutic landscape of GEP-NETs.”
Title: Current Clinical Trial Landscape of Gastroenteropancreatic Neuroendocrine Tumors: A New Era of Landmark Trials
Authors: Supriya Peshin, Shivani Modi, Rodrick Babakhanlou, Junaid Arshad
Read the Full Article on Journal of Clinical Medicine
More posts featuring Neuroendocrine Tumors.